reviewCancer Treatment ReviewsAug 30, 2022GREEN OA

Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy

YFYu FujiwaraSKShumei KatoMNMary NeslineJMJeffrey M. ConroyPDPaul DePietro

Mount Sinai Beth Israel · Icahn School of Medicine at Mount Sinai · +2 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

276
total citations
FWCI
16.02
Percentile
100%
References
116
Citations per year

Authors

7

Topics & keywords

Topics
Keywords
  • Indoleamine 2,3-dioxygenase
  • Medicine
  • Pembrolizumab
  • Blockade
  • Kynurenine
  • Immune checkpoint
  • Cancer research
  • Immunotherapy
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.